top of page
Wordmark_White.png

Coming Together.
Building Connections.
Challenging our Differences.

Accreditation Statements: The Canadian Addiction Counsellors Certification Federation has approved this conference for up to 10.00 continuing education hours (CEU’s) that is valid for two years until March 23, 2028.  Session Number: 2026-02-003.  This activity (303350-001) also has been certified by the College of Family Physicians of Canada for up to 10 Mainpro+® Certified Activity credits.

May 14-15, 2027
The Delta Grand Okanagan

  • Instagram
  • LinkedIn

Please take a few moments to complete our evaluation. The information collected is extremely valuable and will assist in planning future forums!

We would love to hear your feedback!

Share your 
Expertise at our 2025 Forum

The WCAF was built on introducing addiction medicine providers to novel clinical practices that promote positive change in your practice for Monday. For over 13 years, WCAF has honored our humble provincial beginnings as we have grown to reach all of Western Canada and beyond.

Our Conference Hub
Hotel Information

Explore What's Happening Right Now

See you next year 🎉

16:00

​

Conference Concludes

See you next year 🎉

Lisa Graves is a family physician and graduate of the University of Ottawa. She completed her residency in family medicine and enhanced skills training in maternal and child health at McGill University. She maintains an active practice including addictions with a special interest in women, substance use and pregnancy in Northern Ontario. She is an author of over 100 peer-reviewed papers including papers related to substance use and pregnancy/breastfeeding. Her clinical, teaching and research interests include medical education, maternal/child health and vulnerable populations. She is currently professor of Family and Community Medicine at Western Michigan University Homer Stryker M.D. School of Medicine in Kalamazoo Michigan.

_edited_edited.jpg

Attend our Open Narcotics  Anonymous (NA) Meeting 

An opportunity to hear personal experiences of recovery and to gain insight into the  NA  fellowship in a supportive environment. Saturday Morning from 7:00h - 07:45h

WCAF-2.jpg

Congratulate our Innovation Award Winners! 

Celebrating those in opioid use disorder care with three awards related to innovation and recognizing lifetime achievement, early career leadership, and effectuating change in the field.

Making Each Forum Better

The good, the great, and the near misses, we want to hear it all.  

​

​

>> Please fill out our Evaluation Form

Featuring, Big Daddy Tazz.

Big Daddy Tazz xo_edited.jpg

Comedian and Mental Health Advocate  //  For over three decades, Big Daddy Tazz has been inspiring and entertaining audiences across North America with a powerful mix of humor, honesty, and hope. Known as The Bi-Polar Buddha, Tazz brings a unique perspective to every stage — blending world-class stand-up with a meaningful message about mental health, resilience, and workplace well-being.

​

​His presentations use laughter as a bridge to discuss real issues like stress, burnout, and stigma — helping teams connect, recharge, and perform better together.

OUR PRE CONFERENCE WORKSHOP

The Alberta Recovery Model: Building a Recovery Oriented
System of Care

CoRE-Logo-Acronym-CMYK.jpeg

The Western Canada Addiction Forum (WCAF)
and the Canadian Centre of Recovery Excellence (CoRE) is pleased to co-host a full day pre-conference workshop.

The Alberta Recovery Model or recovery-oriented systems of care are showing results, including fewer overdose deaths, better access to care, and improved outcomes for individuals with addiction. The model is receiving increasing attention across the country, with many other provinces starting to move in this direction.

This session will discuss the programs and services specific to the Alberta Recovery Model, along with early research and evaluation results. Come learn how you can build a recovery-oriented system of care into your practice.

​

Distinguished speakers for this workshop includes Kym Kaufmann, Dr. Nathaniel Day, Marshall Smith, Eric Engler and Katy Merrifield.

WCAF25-019.jpg

Securing your Stay for 2026

The Memorial Cup Hockey Tournament will be held at the same time as the 2026 forum.  Hotel rooms are now SOLD OUT.

​

  • The booking is to be made to and from Kelowna, BC.

  • The travel period begins: Friday, May 15, 2026

  • The travel period ends: Sunday, May 31, 2026
     

5% off Econo* and 10% off EconoFlex and Premium fares for travel within Canada and 2% off Econo*, 5% off EconoFlex and 10% off Premium base fares for guests travelling Trans-border.  *No discount will apply to Basic or Business class bookings.

 

Discount Code: 6X6M6BE

Please visit WestJet Conventions to make a booking online.

​

  • The booking is to be made to and from Kelowna, BC.

  • The travel period begins: Friday, May 15, 2026

  • The travel period ends: Sunday, May 31, 2026

 

For North America' 5% applies on standard fares, 10% on flex fares & higher. For International Travel' 10% on standard fares & higher.

 

Discount Code: CY88CH71

Please visit Air Canada to make a booking online.

2027 Innovation in Opioid Use Disorder Care Award Recipients

Effectuating Change in the Field Award

Dr. Nathaniel Day

NathanielDay_edited.jpg

We are very pleased to announce that Dr. Nathaniel Day from Alberta, has been selected as WCAF’s 2026 Effectuating Change in the Field Award recipient. Dr. Day has selected the “Fresh Start Recovery - post-treatment housing” to receive the $10,000 donation from WCAF.

Dr. Sumantra Monty Ghosh is an exemplary physician who has demonstrated outstanding leadership, innovation, and commitment to serving vulnerable populations in Alberta. As an internist and addiction specialist at the University of Alberta Hospital in Edmonton and The Rockyview General Hospital in Calgary, Dr. Ghosh has established himself as a pioneering force in addiction medicine and community health. His academic credentials include addiction certification through the International Society of Addiction Medicine and a Master's in Public Health from Harvard University. As an assistant professor at both the University of Alberta and the University of Calgary, he contributes significantly to medical education while maintaining active clinical practice. Dr. Ghosh's leadership extends beyond clinical care through his role as medical co-lead for the Recovery Alberta Rapid Access Addiction Medicine Program. He currently serves as the president of the section of addiction medicine of the Alberta Medical Association and co-chairs the Canadian Network for the Health and Housing of People Experiencing Homelessness. His research portfolio encompasses critical areas including methamphetamine, opioids, alcohol, healthcare and homelessness, harm reduction, and recovery-oriented treatments. He is currently leading several innovative projects, including the evaluation of virtual supervised consumption through the National Overdose Response Service, methamphetamine toxicity management, and clinical trials in opioid agonist treatment. Dr. Ghosh's commitment to community service is evident through his work with numerous not-for-profit organisations, including The Alex and the Calgary Drop-in Centre, where he develops programmes supporting marginalized populations, particularly those affected by substance use and homelessness. His contributions have been widely recognized through multiple prestigious awards in 2021, including: - Avenue Magazine Top 40 Under 40 - Canadian Medical Association Award for Young Leaders in Early Careers - Alberta Medical Association Award for Compassionate Service - University of Alberta Alumni Horizon Award - Edmonton Zone Medical Staff Association Innovator of the Year Award In 2024, he was the recipient of the 2024 Emerging Public Health Professional Award Dr. Ghosh's influence extends to national discourse through media presence, including notable publications in The Globe and Mail and Policy Options Politics, where he addresses critical issues in addiction medicine and social justice. His work has been supported by major funding bodies including Health Canada, Alberta Innovates, Alberta Health, and the Canadian Institute of Health Research, demonstrating the recognized value and impact of his research initiatives.

Lifetime Achievement Award in Addiction Medicine

Dr. Launette Rieb

Launette Rieb - 1026 copy_edited.jpg

We are very pleased to announce that Dr. Launette Rieb from British Columbia, has been selected as WCAF’s 2026 Lifetime Achievement Award in Addiction Medicine recipient. She has selected “Aunt Leah's Life Skill Society” to receive the $2,500 donation from WCAF.

Dr. MacEwan's contributions to opioid use disorder care relate to his work with those afflicted by severe mental illness and addiction. His contributions to this population in the Vancouver Downtown Eastside are legendary. He has directly trained or been an inspiration to the majority of addiction psychiatrists practicing in the lower mainland of BC. He has been described as a one-man ACT team or guerilla psychiatrist for his longstanding outreach in the downtown eastside of Vancouver to try to reach the severely unwell that suffer several barriers to accessing care. He is a builder. He builds programs (groundbreaking research, clinical, social). He builds links between disparate agencies that service the same population. He builds relationships and trust with some of the most difficult to reach individuals in the province. This population is extremely treatment refractory and so he built strong relationships with agencies outside of healthcare to better advocate for and support these individuals. These individuals are known to be at increased risk of overdose and death and many are too paranoid to trust health providers. He is a trailblazer. He started the refractory psychosis program at Riverview hospital in BC and initiated the first use of clozapine in BC. He developed the largest Early Psychosis Intervention Program in BC. In 2004 he developed the St. Paul's Urban Psychiatry program which is currently a partnership between the Ministry of Justice (through Downtown Community Court, Vancouver Coastal Health and St Paul's Hospital). The primary focus is to provide care to the seriously mentally ill who suffer from substance use disorders and multi morbid illnesses and are not able to access traditional health and mental health care. St. Paul's Hospital services a very complex group of patients who experience treatment refractory psychosis, severe addiction and chronic homelessness. Without the pioneering work of Dr. MacEwan, many of these individuals would have not been able to access care and would not be adequately treated for their opioid or other substance use disorders. He is the clinical lead of the Vancouver Hotel Study which is a 10-year longitudinal CIHR-funded investigation of public health issues in Vancouver’s Downtown Eastside (DTES) that focuses on the intersection of physical and mental health, along with the relationship to drug addiction and access to public health systems. the Hotel Study was launched to better characterize the health needs of the DTES population, with a particular focus on mental health and cognitive function. His contributions are too numerous to include in the space provided, but in short, Dr MacEwan recognized early on that those with severe mental illness and addiction required more than a physician. They needed a new approach, purpose-built programs, more advocates, integration between every agency working with these individuals and new research to direct care and better understand the risks and barriers these individuals experience. Over the course of my career I have met many patients who admit that they would never have given treatment a chance without having met MacEwan first.

Early Career Leadership Award

Dr. Tea Rosic

TeaRosic_edited.jpg

We are very pleased to announce that Dr. Tea Rosic from Ontario, has been selected as WCAF’s 2026 Early Career Leadership Award recipient. She has selected “Rideauwood Addiction and Family
Services” to receive the $2,500 donation from WCAF.

Dr. Danilewitz is a distinguished leader in the field of addiction psychiatry and has made profound contributions to the care of individuals with opioid use disorder (OUD). As the Co-Chair of the Section of Addiction Psychiatry at the Canadian Psychiatric Association (CPA), Dr. Danilewitz has been instrumental in advancing advocacy efforts to improve the integration of psychiatric care in addiction services. His vision has been central in advocating for wraparound care for marginalized individuals, addressing not only their substance use but also their co-occurring mental health needs. This commitment to a holistic approach reflects his dedication to improving the wellbeing of patients, a key criterion for this award. In this capacity he has helped with the development of training guidelines for substance use disorders for Canadian psychiatrists and trainees. Moreover, he has been instrumental in leading policy guidance for addiction psychiatrists in the area of opioid use disorder. Dr Danilewitz has also led critical research in the area of concurrent disorders, including opioid use disorder and psychiatric comorbidities. In particular, he led the development of the first meta-analysis in opioid use disorder and psychotic disorders. Moreover, he has been very active in knowledge translation, presenting at local, national and international meetings on concurrent disorders and opioid use disorder. Dr. Danilewitz's influence extends nationally, both through his leadership at the CPA and his academic work, which promotes the integration of addiction psychiatry into general psychiatric practice. His initiatives in education and advocacy have the potential for broader application across Canada and internationally. His commitment to translating research into clinical practice has led to tangible improvements in patient outcomes, with a focus on sustainable, long-term solutions for OUD. Through his innovation, leadership, and commitment to both patient care and the future of addiction psychiatry, Dr. Marlon Danilewitz exemplifies the qualities recognized by the Innovation in Opioid Use Disorder Care Award. His contributions to the field are far-reaching, and his efforts continue to inspire and shape the future of OUD care in Canada and beyond.

We acknowledge and thank Indivior Canada for the sponsorship that has supported the Western Canada Addiction Forum to be able to provide the three awards related to Innovation in Opioid Use Disorder Care and recognizing excellence in our field.

Nominate for the 2026 Innovation in Opioid Use Disorder Care Awards

Celebrating those who are innovating in opioid use disorder care.  We are honored to offer the following three awards related to innovation and recognizing lifetime achievement, early career leadership, and effectuating change in the field.
Nominate by January 23, 2026.  Awards to be presented at this years forum.

Our 2026 Distinguished Speakers

Martha New cropped_edited_edited.jpg

Dr. Martha Ignaszewski

MD, FRCPC

Dr. Ignaszewski is a Harvard and UCSF trained psychiatrist with board certification in Adult, Addiction, and Child and Adolescent Psychiatry in Canada and the USA. She is the Senior Medical Director of Substance Use and Concurrent Disorders and the Clinical Lead of the Substance Use Response and Facilitation (SURF) Service at BC Children’s and Women’s Hospital, and works as the Education Lead and Consulting Psychiatrist with the Complex Pain and Addiction Service (CPAS) at Vancouver General Hospital. She is also an early career researcher and a Research Scientist Co-Lead of the Substance Use Disorder Clinical Research Unit at the Hope to Health Research & Innovation Complex with the BC Centre for Excellence in HIV/AIDS. Dr. Ignaszewski is passionate about medical education and working with learners across the educational spectrum. Reducing the stigma of addiction and psychiatric conditions, and providing an understanding about the developmental perspective and impacts of social determinants of health on substance use disorders, and the intersection between addiction and concurrent disorders are areas of focus with learners and clinically. Dr. Ignaszewski possesses a background in clinical excellence and research and has held many leadership positions including past roles with the American Academy of Addiction Psychiatry (AAAP) and American Academy of Child and Adolescent Psychiatry (AACAP). She has received many awards in recognition of her work including the inaugural WCAF Early Career Leadership Award in Opioid Use Disorder and is thrilled to be joining the WCAF Planning Committee, and previously has been awarded the ASAM Ruth Fox Scholarship Award, the AACAP Educational Outreach Program Award for Child and Adolescent Psychiatry Residents and the Stuart J. Goldman Psychiatry Education Award, among others. Dr. Ignaszewski has been a speaker at national conferences including the American Psychiatric Association Annual Meeting, the California Society of Addiction Medicine, the American Academy of Child and Adolescent Psychiatry Meeting, and the American Academy of Addiction Psychiatry, and served on the Scientific Program Committee for the 2020 Virtual Annual Conference. She has authored 33 peer reviewed publications and abstracts in notable journals.​

Morris Markentin - image0_edited.jpg

Dr. Morris Markentin

MD, CCFP (AM), FCFP

Dr. Morris Markentin is a family physician and addiction medicine leader based in Saskatoon, Saskatchewan. He is a Clinical Associate Professor with the University of Saskatchewan and has spent over two decades providing comprehensive family medicine with a focus on addiction care, HIV, Hepatitis C, and underserved populations. Dr. Markentin is the co-founder and Medical Director of Sanctum Care Group and co-founder and Medical Director of The Carter House - A Family Addiction Treatment Center. Dr Markentin also serves as Medical Manager of Saskatchewan’s Opiate Agonist Therapy Program. He has held numerous provincial and national leadership roles in family and addiction medicine and is the recipient of multiple awards recognizing excellence in clinical care, leadership, and community service.

Dr. Annabel Mead

MBBS, FAChAM, DABAM

Physician (Specialist in Addiction Medicine)

Practicing addiction medicine for over 20 years with expertise in women’s health, concurrent psychiatric disorders and pain management. She is a Fellow of the Australasian Chapter of Addiction Medicine, a diplomate of the American Board of Addiction Medicine and Clinical Assistant Professor, UBC. Dr. Mead has worked in many community, inpatient and outpatient treatment settings in Vancouver. These include the Addiction Medicine Consult Service at St Paul’s Hospital and New Dawn Recovery House. She holds the positions of Senior Medical Director, Mental Health and Substance Use, BC Women’s Hospital; Medical Director for BC Correctional Health Services and is the medical lead for the BC Provincial Perinatal Substance Use program.

Dr. Rob Tanguay

BSc (Hons), MD, FRCPC, CISAM, CCSAM 

Dr. Robert Tanguay is a psychiatrist with dual fellowships in Addiction Medicine and Pain Medicine. He is a Clinical Assistant Professor in the Departments of Psychiatry and Surgery at the Cumming School of Medicine, University of Calgary. He currently serves as the Senior Medical Director, Addiction Services, for Recovery Alberta, and is the co-founder and co-developer of Alberta’s Community Rapid Access Addiction Medicine (RAAM) clinics, where he continues to practice clinically. Dr. Tanguay is a member of the Calgary Police Commission, providing leadership on budget, governance, and policy to support effective and accountable policing. Nationally, he serves as Co-Chair of the Western Canadian Addiction Forum and Chair of the Canadian Addiction Council, and is a founding director of the Canadian Academy of Addiction Psychiatry. He has played a significant role in health and addiction policy in Alberta and beyond. Dr. Tanguay helped lead both the Alberta Psychedelic Legislative Committee and the Alberta Safe Supply Legislative Committee, and was a member of the Alberta Recovery Expert Advisory Panel, directly advising the Minister of Mental Health and Addiction. He previously served on the Public Health Emergencies Governance Review Panel, the Supervised Consumption Review Committee, and has provided expert testimony to the Oregon State Senate, the Alberta Legislature, and the Parliament of Canada as part of international and national policy advisory efforts. Dr. Tanguay’s contributions have been recognized with numerous honours, including the Royal College Early Career Leadership Award, induction into the University of Lethbridge Alumni Honour Society, the University of Calgary Department of Psychiatry Keith Pierce Award for Innovation, the Queen Elizabeth II Platinum Jubilee Medal, and the King Charles III Coronation Medal. An active academic and educator, Dr. Tanguay has delivered more than 170 invited, plenary, and keynote presentations across three continents on addiction, pain, mental health, and public policy. He has secured nearly $10 million in operational and research funding. His research focuses on trauma, addiction, chronic pain, opioids, cannabis, and psychedelics. He is a member of both the Hotchkiss Brain Institute and the Mathison Centre for Mental Health Research & Education at the University of Calgary.

Must See Sessions

Out of My Mind: Finding Laughter, Lessons, and Leadership in Mental Health  •  The Intersection of Sleep and Addiction  •  Catatonia due to withdrawal from ‘benzo-dope' in controlled environments: an analysis of two cases with co-occurring disorders  •  Beyond Harm Reduction: Proactive Approaches to Substance Use and Mental Health  •  Family members’ perspectives of laws, policies and practices in substance use disorder treatment: A qualitative focus on involuntary treatment  •  Testimony of Recovery  •  Nicotine and Person-Centred Care  •  FROM METABOLISM TO MOTIVATION: The Role of GLP-1 Receptor Agonists in AUD and OUD  •  Life Beyond Addiction  •  Beyond Dispensing: Re-imagining Pharmacists’ role in MHSU care  •  Becoming Unshakeable: My Story of Recovery and Renewal  •  Uniformed Professionals in Canada - Mental Health and Substance Use Disorders and Treatment  •  Innovative Strategies in the Fentanyl Era  •  Decriminalization: What went wrong in Oregon and BC compared to Portugal?  •  A Province-Wide Clinical Care Pathway for Youth Who Use Substances  •  The “Wellness Wheel”: A Sharing of a framework of how I reconcile as an Indigenous Provider: The balance of pharmaceutical and non-pharmaceutical ways of healing in substance use disorders and mental health conditions  •  Youth Nicotine Use: Treatment considerations  •  Medical monitoring in safety sensitive individuals  •  Hepatitis C in Primary Care: A Practical National Test-and-Treat Toolkit  •  How Do We Reduce Harm for People Who Continue to Struggle With Opioid Use?  •  Strength in Relationship: Indigenous Led Recovery Communities and Sustainable Recovery Outcomes  •  Policing Collaboration in Addiction Services: A Comparison Review of Policy and Subsequent Outcomes

Our Planning Committee

Dr. Rob Tanguay

Conference Co-Chair
BSc (Hons), MD, FRCPC, CISAM, CCSAM
Calgary, Alberta

Dr. Annabel Mead

Conference Co-Chair
MBBS, FAChAM, DABAM
Vancouver, British Columbia

NBootsman_Vertical_edited.jpg

Nicole Bootsman

BPharm 

Saskatoon, Saskatchewan

Dr. George Budd

PharmD, FBCCSU, B.Sc.(Pharm), RPEBC, R.Ph
Vancouver, British Columbia

Joan Hollihan

B.Comm
Calgary, Alberta

Dr. Martha Ignaszewski

MD, FRCPC

Vancouver, British Columbia

Morris Markentin - image0_edited.jpg

Dr. Morris Markentin

MD, CCFP (AM), FCFP
Saskatoon, Saskatchewan

Delta Grand Okanagan

1310 Water St, Kelowna, BC

Immerse yourself in a lakeside ambiance at Delta Hotels by Marriott Grand Okanagan Resort. Set on Okanagan Lake and surrounded by picturesque mountains, their urban resort offers stylish hotel rooms and suites with deluxe amenities.

​

Experience the Delta Hotels by Marriott Grand Okanagan Resort at our event, May 26-27, 2023.

Continue Connecting with Us!

Keep an eye out for our exciting developments!

14

Sessions

20

Speakers

Reconciliation Comes First

The Western Canada Addiction Forum would like to acknowledge the land on which we gather is the unceded territory of the Syilx (Okanagan) Peoples. The Syilx Okanagan Nation and their peoples have taken care of their homelands for thousands of years.

 

WCAF is respectful of the Syilx Okanagan Nation and their peoples, their knowledge, language, and history, as well as their ongoing relationship to the land and natural world.

Wordmark_Seafoam.png

Recovery Redefined

Contact Us

Thank you for your Inquiry.  We'll be in contact soon!

bottom of page